Pharma Mar S.A. (PHM) — Working Capital to Net Assets Ratio
Pharma Mar S.A. (PHM) has a Working Capital to Net Assets ratio of 75.3% as of December 2025. Working capital of €189.54 Million (current assets of €283.42 Million minus current liabilities of €93.88 Million) is measured against net assets of €251.83 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See PHM equity financing ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Pharma Mar S.A. Working Capital to Net Assets (2002–2025)
This chart shows how Pharma Mar S.A.'s Working Capital to Net Assets ratio has evolved across 24 annual periods from 2002 to 2025. As of December 2025, the ratio stands at 75.3%, reflecting working capital of €189.54 Million against net assets of €251.83 Million EUR. Check PHM tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Pharma Mar S.A. (2002–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Pharma Mar S.A. from 2002 to 2025, covering 24 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see PHM market cap.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 75.3% | €189.54 Million | €251.83 Million | €283.42 Million | €93.88 Million | ▼ -5.2 pp |
| 2024 | 80.4% | €167.55 Million | €208.36 Million | €250.25 Million | €82.69 Million | ▼ -0.6 pp |
| 2023 | 81.0% | €156.71 Million | €193.44 Million | €252.60 Million | €95.89 Million | ▲ +1.2 pp |
| 2022 | 79.8% | €177.86 Million | €222.96 Million | €275.18 Million | €97.32 Million | ▼ -37.6 pp |
| 2021 | 117.4% | €208.88 Million | €177.92 Million | €295.23 Million | €86.35 Million | ▼ -29.3 pp |
| 2020 | 146.7% | €150.73 Million | €102.72 Million | €245.65 Million | €94.92 Million | ▲ +287.1 pp |
| 2019 | -140.3% | €-10.46 Million | €7.46 Million | €49.98 Million | €60.44 Million | ▼ -155.9 pp |
| 2018 | 15.6% | €2.73 Million | €17.47 Million | €75.11 Million | €72.38 Million | ▼ -28.2 pp |
| 2017 | 43.8% | €10.07 Million | €22.98 Million | €93.18 Million | €83.11 Million | ▼ -26.0 pp |
| 2016 | 69.8% | €33.83 Million | €48.49 Million | €120.99 Million | €87.16 Million | ▲ +12.9 pp |
| 2015 | 56.8% | €41.51 Million | €73.04 Million | €112.14 Million | €70.62 Million | ▲ +24.7 pp |
| 2014 | 32.1% | €19.29 Million | €60.07 Million | €101.92 Million | €82.63 Million | ▼ -12.1 pp |
| 2013 | 44.2% | €21.84 Million | €49.44 Million | €95.89 Million | €74.06 Million | ▼ -5.1 pp |
| 2012 | 49.3% | €19.08 Million | €38.73 Million | €106.43 Million | €87.36 Million | ▼ -67.2 pp |
| 2011 | 116.4% | €40.16 Million | €34.50 Million | €129.53 Million | €89.37 Million | ▲ +1.4 pp |
| 2010 | 115.0% | €40.09 Million | €34.86 Million | €143.41 Million | €103.32 Million | ▼ -17.4 pp |
| 2009 | 132.4% | €54.48 Million | €41.14 Million | €126.39 Million | €71.91 Million | ▲ +11.7 pp |
| 2008 | 120.8% | €59.60 Million | €49.34 Million | €124.92 Million | €65.32 Million | ▲ +25.5 pp |
| 2007 | 95.2% | €94.11 Million | €98.81 Million | €149.57 Million | €55.45 Million | ▲ +31.1 pp |
| 2006 | 64.2% | €68.79 Million | €107.17 Million | €138.01 Million | €69.22 Million | ▼ -12.5 pp |
| 2005 | 76.7% | €275.99 Million | €360.04 Million | €299.88 Million | €23.89 Million | ▲ +3.5 pp |
| 2004 | 73.2% | €220.40 Million | €301.23 Million | €239.10 Million | €18.70 Million | ▲ +6.4 pp |
| 2003 | 66.8% | €92.97 Million | €139.28 Million | €162.97 Million | €70.00 Million | ▲ +0.8 pp |
| 2002 | 66.0% | €110.13 Million | €166.90 Million | €169.98 Million | €59.85 Million | — |